NERVE SURGERY CENTRE LIMITED
Significant control: Tomas Madura (25–50%), Imai Yukiko (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Nerve Surgery Centre Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NERVE SURGERY CENTRE LIMITED is an active private limited company (company number 14701499) incorporated on 2 March 2023, registered in Wilmslow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of −£3,866, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 42% on the prior period (−£6,685).
By net assets it sits in the lower half of 138 comparable companies in Manchester (median £436, upper quartile £124k).
Ownership and control
- Dr Tomas Madura
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Imai Yukiko
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 2 March 20233 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 16 March 2027in 144 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- SIC 86220
- Specialists medical practice activities
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£3,866 | — | — | — | — | — | 2 |
| 31 March 2024 | −£6,685 | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-3,866 at 31 March 2025
- Net assets up 10% or more on the prior period+42.2% vs prior period
- Incorporated two to five years agoIncorporated 2 March 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 144 days
- Next accounts duein 69 days
- Accounts period endNet liabilities £3,866 · micro accounts
- Accounts period endNet liabilities £6,685 · micro accounts
- Incorporated
Similar companies in Manchester
- ARTBIO LIMITEDAltrincham · inc. Mar 2023
- CYTOSPIRE THERAPEUTICS LIMITEDAltrincham · inc. Feb 2023
- PRISTINE HEALTH SOLUTIONS LIMITEDManchester · inc. Feb 2023
- SENSIBLE BIOTECHNOLOGIES LIMITEDAltrincham · inc. Jan 2023
- BLACKFINBIO LIMITEDAltrincham · inc. Jan 2023
- AKL THERAPEUTICS LIMITEDManchester · inc. Jan 2023
All companies incorporated on 2 March 2023 · in Mar 2023.
Reminders for NERVE SURGERY CENTRE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.